A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States

Background: This analysis compares the cost-effectiveness of a cell-based influenza vaccine to a recombinant influenza vaccine, and each to no vaccination. The analysis is based on United States (US) commercial and societal perspectives. Methods: A Susceptible–Exposed–Infectious–Recovered (SEIR) tra...

Full description

Saved in:
Bibliographic Details
Main Authors: Myron J. Levin, Neda Al Rawashdh, Liliane Mofor, Pablo Anaya, Richard M. Zur, Emily B. Kahn, Daniel Yu, Joaquin F. Mould-Quevedo
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/11/1217
Tags: Add Tag
No Tags, Be the first to tag this record!